It includes multiple trials studying retatrutide in different populations: TRIUMPH-1 (obesity/overweight without type 2 diabetes, NCT05929066), TRIUMPH-3 (severe obesity + cardiovascular disease, NCT05882045), TRIUMPH-9 (dose-escalation in obesity, NCT07357415), and TRIUMPH-Outcomes (cardiovascular and kidney outcomes in adults with obesity, NCT06383390)
For injection technique details, see what is a peptide injection
Saxenda, also a once daily injection, is approved for weight loss in children at least 12 years old and adults diagnosed with obesity
Hold the pen or syringe at a 90-degree angle to your skin, pinching the injection site gently between your thumb and forefinger to create a small mound of tissue
Medical Weight Loss Initial Visit One-time initial fee
Stress, poor nutrition, environmental toxins, and ongoing oxidative stress can all contribute to lower levels